These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 1898612)
21. Requirements for C5a receptor-mediated IL-4 and IL-13 production and leukotriene C4 generation in human basophils. Eglite S; Plüss K; Dahinden CA J Immunol; 2000 Aug; 165(4):2183-9. PubMed ID: 10925305 [TBL] [Abstract][Full Text] [Related]
22. Characteristics of arachidonic acid generation in human basophils: relationship between the effects of inhibitors of secretory phospholipase A2 activity and leukotriene C4 release. Hundley TR; Marshall LA; Hubbard WC; MacGlashan DW J Pharmacol Exp Ther; 1998 Mar; 284(3):847-57. PubMed ID: 9495842 [TBL] [Abstract][Full Text] [Related]
23. Neutrophil chemotactic factors promote leukocytosis. A common mechanism for cellular recruitment from bone marrow. Jagels MA; Hugli TE J Immunol; 1992 Feb; 148(4):1119-28. PubMed ID: 1310708 [TBL] [Abstract][Full Text] [Related]
24. Graded changes in the response of individual human basophils to stimulation: distributional behavior of early activation events. MacGlashan DW; Bochner BS; Warner JA J Leukoc Biol; 1994 Jan; 55(1):13-23. PubMed ID: 7506746 [TBL] [Abstract][Full Text] [Related]
25. Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation. Clancy RM; Dahinden CA; Hugli TE Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7200-4. PubMed ID: 6417666 [TBL] [Abstract][Full Text] [Related]
26. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells. Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332 [TBL] [Abstract][Full Text] [Related]
27. Dual phase priming by IL-3 for leukotriene C4 generation in human basophils: difference in characteristics between acute and late priming effects. Miura K; MacGlashan DW J Immunol; 2000 Mar; 164(6):3026-34. PubMed ID: 10706691 [TBL] [Abstract][Full Text] [Related]
28. Nucleotide-, chemotactic peptide- and phorbol ester-induced exocytosis in HL-60 leukemic cells. Wenzel-Seifert K; Seifert R Immunobiology; 1990 Nov; 181(4-5):298-316. PubMed ID: 1966023 [TBL] [Abstract][Full Text] [Related]
29. The role of basophils in allergic disease. Knol EF; Mul FP; Lie WJ; Verhoeven AJ; Roos D Eur Respir J Suppl; 1996 Aug; 22():126s-131s. PubMed ID: 8871057 [TBL] [Abstract][Full Text] [Related]
30. Differential activation of human basophils by anti-IgE and formyl-methionyl-leucyl-phenylalanine. Indications for protein kinase C-dependent and -independent activation pathways. Knol EF; Koenderman L; Mul FP; Verhoeven AJ; Roos D Eur J Immunol; 1991 Apr; 21(4):881-5. PubMed ID: 1708341 [TBL] [Abstract][Full Text] [Related]
31. Maitotoxin, a novel activator of mediator release from human basophils, induces large increases in cytosolic calcium resulting in histamine, but not leukotriene C4, release. Columbo M; Taglialatela M; Warner JA; MacGlashan DW; Yasumoto T; Annunziato L; Marone G J Pharmacol Exp Ther; 1992 Dec; 263(3):979-86. PubMed ID: 1281881 [TBL] [Abstract][Full Text] [Related]
32. Differential cholera-toxin- and pertussis-toxin-catalysed ADP-ribosylation of G-proteins coupled to formyl-peptide and leukotriene B4 receptors. Schepers TM; McLeish KR Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):469-73. PubMed ID: 8380997 [TBL] [Abstract][Full Text] [Related]
33. Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue. Seifert R; Höer A; Offermanns S; Buschauer A; Schunack W Mol Pharmacol; 1992 Aug; 42(2):227-34. PubMed ID: 1381043 [TBL] [Abstract][Full Text] [Related]
34. Complement- and IgE-mediated release of histamine from basophils in vitro. V. Differential effects of drugs modulating arachidonic acid metabolism. Farnam J; Grant JA; Lett-Brown MA; Hunt C; Thueson DO; Giclas PC J Immunol; 1985 Jan; 134(1):541-7. PubMed ID: 2578053 [TBL] [Abstract][Full Text] [Related]
35. The degradation product of the C5a anaphylatoxin C5adesarg retains basophil-activating properties. Bürgi B; Brunner T; Dahinden CA Eur J Immunol; 1994 Jul; 24(7):1583-9. PubMed ID: 7517876 [TBL] [Abstract][Full Text] [Related]
36. Biphasic Ca2+ responses in human basophils. Evidence that the initial transient elevation associated with the mobilization of intracellular calcium is an insufficient signal for degranulation. MacGlashan D; Botana LM J Immunol; 1993 Feb; 150(3):980-91. PubMed ID: 7678630 [TBL] [Abstract][Full Text] [Related]
37. IgE-independent interleukin-4 expression and induction of a late phase of leukotriene C4 formation in human blood basophils. Ochensberger B; Rihs S; Brunner T; Dahinden CA Blood; 1995 Dec; 86(11):4039-49. PubMed ID: 7492759 [TBL] [Abstract][Full Text] [Related]
38. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Bischoff SC; Dahinden CA Blood; 1992 May; 79(10):2662-9. PubMed ID: 1586715 [TBL] [Abstract][Full Text] [Related]
39. The effect of pertussis toxin on mediator release from human basophils. Warner JA; Yancey KB; MacGlashan DW J Immunol; 1987 Jul; 139(1):161-5. PubMed ID: 2438348 [TBL] [Abstract][Full Text] [Related]
40. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids. Schleimer RP; Derse CP; Friedman B; Gillis S; Plaut M; Lichtenstein LM; MacGlashan DW J Immunol; 1989 Aug; 143(4):1310-7. PubMed ID: 2473127 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]